Cancel

Request a live demo presentation

One of our sales representative will call you soon


By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

We have generated thousand of leads for our happy customers

  • company
  • company
  • company
  • company
  • company
  • company
  • company
  • company

LOQUS23 THERAPEUTICS LIMITED Active

Scientific & Education


Contact information


Unlock Company Insights Free Access

Get instant access to key company data, decision-maker contacts, and verified insights.

Start for Free now

Financial statements of LOQUS23 THERAPEUTICS LIMITED

According to LOQUS23 THERAPEUTICS LIMITED latest financial report submitted on 2024-03-31, the company has a Turnover of £20,576.00, Gross-Profit of £20,576.00 while the Cash is £2M. Compared with the previous year, the company reported a Turnover increase of 2.8%, which is an equivalent of -576. At the same time, the Gross-Profit went up by 2.8%, or by -576.


Year:
2023 Not available
2022 Not available
2021 Not available
2020 Not available

Access 20 Years of Financial Data

Start for free
  • Reporting period

    12

  • Consolidated A/cs

    N

  • Profit after Tax

    £ -

  • Working Capital

    £ -

Profit after Tax

LOQUS23 THERAPEUTICS LIMITED Business Credit Report

A Business Credit Report for LOQUS23 THERAPEUTICS LIMITED is available for instant download. The report will provide you with a credit score and credit limit recommendation for LOQUS23 THERAPEUTICS LIMITED, payment trends, if the company pays their Invoices on time, whether or not the company has any court judgements, ownership and group structure, up to 5 years of financial statements and much more. When you buy a Credit Report from Global Database, you will also have a 7 days free trial to our B2B Sales Platform.


Overall Credit Risk for

LOQUS23 THERAPEUTICS LIMITED

Unlock Credit Report

For more information you can

Key features

  • Credit Score and Credit Limit
  • Financial accounts for the past 5 years
  • Credit Officers
  • Document Filing history
  • Corporate Ownership
  • Outstanding & Satisfied Mortgages
  • Shareholder Information
  • Company Identity

LOQUS23 THERAPEUTICS LIMITED Directors and key executives

LOQUS23 THERAPEUTICS LIMITED currently employs 5 people. Compared with the previous year, the company has reported a staff increase of 67%, which is an equivalent of 2 employees.
In order to view contact information, including emails and phone numbers for all the employees working at LOQUS23 THERAPEUTICS LIMITED and to export them in XL or to your existing CRM, you can subscribe to our platform here.


Total Employee Count

Total employees

5

167%

1y growth

100%

2y growth

Management Level


100

Middle

Employee Job Title Email Phone Country
Melanie Ivarsson Director
-
- GB
Jonathon Dines Director
-
- GB
David Reynolds Director
-
- GB
Christian Jung Director
-
- GB
Florian Muellershausen Director
-
- GB

Get direct emails & phone numbers for senior executives working at «LOQUS23 THERAPEUTICS LIMITED»

Download our chrome extension and enrich prospect profiles in seconds. Organize contacts into focus lists, send e-mails or embed leads into automated sequences straight off their Linkedin profile - without leaving the browser.

Download Extension

LOQUS23 THERAPEUTICS LIMITED Ownership and Group Structure

Explore the Full Corporate Tree.

Uncover parent companies, subsidiaries, and global linkages

Start Free Now

LOQUS23 THERAPEUTICS LIMITED Shareholders and Ultimate Beneficial Owners (UBO)

There are currently 5 people with significant control at LOQUS23 THERAPEUTICS LIMITED. One of of major shareholders of LOQUS23 THERAPEUTICS LIMITED is DDF PARALLEL LLP, which owns 107260 SERIES SEED EXTENSION PREFERRED shares, with a total value of 0 GBP and DEMENTIA DISCOVERY GP LP ACTING AS GENERAL PARTNER OF, which owns 6548666 SERIES SEED EXTENSION PREFERRED shares, with a total value of 0 GBP and NOVARTIS BIOVENTURES LTD, which owns 962330 SERIES SEED EXTENSION PREFERRED shares, with a total value of 0 GBP and CAROLINE VAN DER WESTHUIZEN, which owns 250000 ORDINARY shares, with a total value of 0 GBP and RUTH MCKERNAN, which owns 125000 ORDINARY shares, with a total value of 0 GBP.


Name Quantity Share Type Value
DDF PARALLEL LLP
107260 SERIES SEED EXTENSION PREFERRED 0 GBP
DEMENTIA DISCOVERY GP LP ACTING AS GENERAL PARTNER OF
6548666 SERIES SEED EXTENSION PREFERRED 0 GBP
NOVARTIS BIOVENTURES LTD
962330 SERIES SEED EXTENSION PREFERRED 0 GBP
CAROLINE VAN DER WESTHUIZEN
250000 ORDINARY 0 GBP
RUTH MCKERNAN
125000 ORDINARY 0 GBP

See All Beneficial Owners & Shareholders

Unlock Full Access For Free

LOQUS23 THERAPEUTICS LIMITED competitors:

Top 5 similar companies of LOQUS23 THERAPEUTICS LIMITED are IG INNOVATIONS LIMITED, VENN LIFE SCIENCES (NI) LTD., AUVATION LIMITED, BLUEBIRD BIO (UK) LTD., ORION CLINICAL SERVICES (AUSTRALIA) PTY LIMITED. View and export all the competitor list of LOQUS23 THERAPEUTICS LIMITED by upgrading your account here.


IG INNOVATIONS LIMITED


Revenue
155,000.0
Age
15 years
Employees
5
Industry
View Scientific & Education
Website
View http://ig-innov*************

VENN LIFE SCIENCES (NI) LTD.


Revenue
80,837.0
Age
24 years
Employees
5
Industry
View Scientific & Education
Website
View http://med*********

AUVATION LIMITED


Revenue
37,061.0
Age
29 years
Employees
6
Industry
View Scientific & Education
Website
View http://auva*********

BLUEBIRD BIO (UK) LTD.


Revenue
5,691.0
Age
9 years
Employees
1
Industry
View Scientific & Education
Website
View http://blueb***********

ORION CLINICAL SERVICES (AUSTRALIA) PTY LIMITED


Revenue
12,391.0
Age
24 years
Employees
1
Industry
View Scientific & Education
Website
View http://www.simbe**************

View & Export LOQUS23 THERAPEUTICS LIMITED competitors:

Get the complete list with detailed profiles

Start For Free

LOQUS23 THERAPEUTICS LIMITED news & activities:


Turnover

LOQUS23 THERAPEUTICS LIMITED has submitted new account statements and has reported a turnover of £20,576.00, a 2.8% decrease year-over-year.

uk.globaldatabase.com

2024-03-31

Employees

LOQUS23 THERAPEUTICS LIMITED number of employees has increased by 67% compared with previous year and now represents a total number of 5.

uk.globaldatabase.com

2024-03-31

Stay Ahead with Real-Time Insights

Monitor key metrics and company activity

Start For Free

Frequently Asked Questions regarding LOQUS23 THERAPEUTICS LIMITED


Where is LOQUS23 THERAPEUTICS LIMITED registered office?

LOQUS23 THERAPEUTICS LIMITED is located at Suite 7 Mcclintock Building Granta Park, United Kingdom.

What is the website of LOQUS23 THERAPEUTICS LIMITED?

LOQUS23 THERAPEUTICS LIMITED website is http://loqus23.com/

How many people work at LOQUS23 THERAPEUTICS LIMITED?

According to the latest account statement, there are currently 5 of employees working for LOQUS23 THERAPEUTICS LIMITED.

How much revenue does LOQUS23 THERAPEUTICS LIMITED make?

Based on the latest financial accounts submitted on 2024-03-31, the company made £20,576.00 for 2024, which went up by 2.8%.

What is the Business Credit Score of LOQUS23 THERAPEUTICS LIMITED and how reliable is the company?

In order to check the business credit score of LOQUS23 THERAPEUTICS LIMITED, you can request a credit report. You will view the latest credit limit information, ownership, group structure, court judgements and much more.

Does LOQUS23 THERAPEUTICS LIMITED pay their invoices on time?

By requesting a Business Credit Report for LOQUS23 THERAPEUTICS LIMITED, you will be able to gain more insights about the LOQUS23 THERAPEUTICS LIMITED payment trends.

Access 100% verified registry data via API—company profiles, group structures, UBOs, financials, and more.

Explore API Access

Search for International Credit Report

0 results
Name
Arrow Arrow
City
Arrow Arrow
Address
Arrow Arrow
Reg. No
Arrow Arrow
Status
Arrow Arrow
Action